Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.
Saved in:
| Title: | Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. |
|---|---|
| Authors: | Niesvizky, Ruben1 (AUTHOR) run9001@med.cornell.edu, Martínez-Baños, Déborah1 (AUTHOR), Jalbrzikowski, Jessica1 (AUTHOR), Christos, Paul2 (AUTHOR), Furst, Jessica1 (AUTHOR), De Sancho, Maria1 (AUTHOR), Mark, Tomer1 (AUTHOR), Pearse, Roger1 (AUTHOR), Mazumdar, Madhu2 (AUTHOR), Zafar, Faiza1 (AUTHOR), Pekle, Karen1 (AUTHOR), Leonard, John1 (AUTHOR), Jayabalan, David1 (AUTHOR), Coleman, Morton1 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Dec2007, Vol. 48 Issue 12, p2330-2337. 8p. 6 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428190701647887 |